A carregar...

Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment

PURPOSE: Hypertension is a mechanism-based toxicity of sorafenib and other cancer therapeutics that inhibit the vascular endothelial growth factor (VEGF) signaling pathway (VSP). This prospective, single center, cohort study characterized ambulatory blood pressure (BP) monitoring (ABPM) as an early...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maitland, Michael L., Kasza, Kristen E., Karrison, Theodore, Moshier, Kristin, Sit, Laura, Black, Henry R., Undevia, Samir D., Stadler, Walter M., Elliott, William J., Ratain, Mark J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756980/
https://ncbi.nlm.nih.gov/pubmed/19773379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0058
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!